BAMCO Inc
DPLO

BAMCO Inc’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BAMCO Inc’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,282,664
Closed -$35.9M – 337
2016
Q3 		$35.9M Sell
1,282,664
-68,250
-5% -$2.29M 0.19% 123
2016
Q2 		$47.3M Sell
1,350,914
-52,905
-4% -$1.66M 0.25% 93
2016
Q1 		$38.5M Sell
1,403,819
-945,234
-40% -$27.8M 0.2% 126
2015
Q4 		$80.4M Buy
2,349,053
+63,444
+3% +$1.98M 0.37% 71
2015
Q3 		$65.7M Sell
2,285,609
-4,000
-0.2% -$171K 0.3% 86
2015
Q2 		$102M Buy
2,289,609
+210,234
+10% +$7.91M 0.4% 72
2015
Q1 		$71.9M Buy
2,079,375
+2,004,375
+2,673% +$54.5M 0.28% 94
2014
Q4 		$2.05M Buy
+75,000
New +$1.82M 0.01% 289

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BAMCO Inc's DPLO Position: Q4 2016 in Review

BAMCO Inc sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 1,282,664 shares — an estimated $35.9M sold.

BAMCO Inc first reported a position in DPLO in Q4 2014 and held it in 8 quarters. The position peaked at $102M in Q2 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • BAMCO Inc reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • BAMCO Inc sold 1,282,664 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $35.9M.
  • BAMCO Inc first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 8 quarters.
  • BAMCO Inc's DIPLOMAT PHARMACY, INC. position peaked at $102M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BAMCO Inc's 13F filing for Q4 2016, filed 14 Feb 2017.